KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash from Financing Activities (2019 - 2025)

Historic Cash from Financing Activities for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to -$65.8 million.

  • GoodRx Holdings' Cash from Financing Activities rose 6176.53% to -$65.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$225.2 million, marking a year-over-year increase of 5100.35%. This contributed to the annual value of -$337.5 million for FY2024, which is 10161.59% down from last year.
  • Per GoodRx Holdings' latest filing, its Cash from Financing Activities stood at -$65.8 million for Q3 2025, which was up 6176.53% from -$50.9 million recorded in Q2 2025.
  • Over the past 5 years, GoodRx Holdings' Cash from Financing Activities peaked at -$864000.0 during Q2 2024, and registered a low of -$172.1 million during Q3 2024.
  • For the 5-year period, GoodRx Holdings' Cash from Financing Activities averaged around -$46.2 million, with its median value being -$14.0 million (2021).
  • Per our database at Business Quant, GoodRx Holdings' Cash from Financing Activities surged by 9718.96% in 2024 and then crashed by 579444.44% in 2025.
  • Over the past 5 years, GoodRx Holdings' Cash from Financing Activities (Quarter) stood at -$11.5 million in 2021, then soared by 58.26% to -$4.8 million in 2022, then tumbled by 2524.43% to -$125.6 million in 2023, then soared by 97.19% to -$3.5 million in 2024, then plummeted by 1764.39% to -$65.8 million in 2025.
  • Its last three reported values are -$65.8 million in Q3 2025, -$50.9 million for Q2 2025, and -$104.9 million during Q1 2025.